Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,818 | -20,023 | -13,832 | -9,900 | -5,152 |
| Depreciation Amortization | 93 | 246 | 167 | 102 | 50 |
| Accounts receivable | 35 | -392 | -180 | N/A | N/A |
| Accounts payable and accrued liabilities | 407 | -149 | 732 | 82 | 432 |
| Other Working Capital | 30,707 | 264 | 616 | 807 | 1,020 |
| Other Operating Activity | 623 | 3,244 | 1,315 | 1,065 | 321 |
| Operating Cash Flow | $24,047 | $-16,809 | $-11,182 | $-7,844 | $-3,329 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -625 | -1,196 | -828 | -359 | -37 |
| Investing Cash Flow | $-625 | $-1,196 | $-828 | $-359 | $-37 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28 | 20,225 | 20,183 | 13,615 | 12,580 |
| Financing Cash Flow | $28 | $20,225 | $20,183 | $13,615 | $12,580 |
| Beginning Cash Position | 34,885 | 32,666 | 32,666 | 32,666 | 32,666 |
| End Cash Position | 58,334 | 34,885 | 40,839 | 38,078 | 41,880 |
| Net Cash Flow | $23,449 | $2,219 | $8,173 | $5,412 | $9,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,047 | -16,809 | -11,182 | -7,844 | -3,329 |
| Capital Expenditure | -625 | -1,196 | -828 | -359 | -37 |
| Free Cash Flow | 23,421 | -18,006 | -12,009 | -8,203 | -3,366 |